Article Information
History
- November 27, 2020.
Article Versions
- Version 1 (October 28, 2020 - 06:48).
- You are currently viewing Version 2 of this article (November 27, 2020 - 13:55).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Emma B. Hodcroft1,2,3,*,
- Moira Zuber1,
- Sarah Nadeau4,2,
- Katharine H. D. Crawford5,6,7,
- Jesse D. Bloom5,6,8,
- David Veesler9,
- Timothy G. Vaughan4,2,
- Iñaki Comas10,11,12,
- Fernando González Candelas13,11,12,
- SeqCOVID-SPAIN consortium14,
- Tanja Stadler4,2 and
- Richard A. Neher1,2
- 1Biozentrum, University of Basel, Basel, Switzerland
- 2Swiss Institute of Bioinformatics, Basel, Switzerland
- 3Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- 4D-BSSE, ETHZ, Basel, Switzerland
- 5Division of Basic Sciences and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
- 6Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA
- 7Medical Scientist Training Program, University of Washington, Seattle, WA 98195, USA
- 8Howard Hughes Medical Institute, Seattle, WA 98103, USA
- 9Department of Biochemistry, University of Washington, Seattle, WA, USA
- 10Tuberculosis Genomics Unit, Biomedicine Institute of Valencia (IBV-CSIC), Valencia, Spain
- 11CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
- 13Joint Research Unit “Infection and Public Health” FISABIO-University of Valencia, Institute for Integrative Systems Biology (I2SysBio), Valencia, Spain
- ↵* Corresponding author; email: emma.hodcroft{at}unibas.ch